Cargando…

Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images

BACKGROUND: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a newly defined autoimmune inflammatory demyelinating central nervous system (CNS) disease characterized by antibodies against MOG. Leptomeningeal enhancement (LME) on contrast-enhanced fluid-attenuated inversion recovery (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Liu, Wen, Cai, Qifang, Liu, Yuqing, Hu, Wenjing, Zuo, Zhichao, Ma, Qiuhong, He, Siping, Jin, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318903/
https://www.ncbi.nlm.nih.gov/pubmed/37409120
http://dx.doi.org/10.3389/fimmu.2023.1152235
_version_ 1785068137549398016
author Li, Li
Liu, Wen
Cai, Qifang
Liu, Yuqing
Hu, Wenjing
Zuo, Zhichao
Ma, Qiuhong
He, Siping
Jin, Ke
author_facet Li, Li
Liu, Wen
Cai, Qifang
Liu, Yuqing
Hu, Wenjing
Zuo, Zhichao
Ma, Qiuhong
He, Siping
Jin, Ke
author_sort Li, Li
collection PubMed
description BACKGROUND: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a newly defined autoimmune inflammatory demyelinating central nervous system (CNS) disease characterized by antibodies against MOG. Leptomeningeal enhancement (LME) on contrast-enhanced fluid-attenuated inversion recovery (CE-FLAIR) images has been reported in patients with other diseases and interpreted as a biomarker of inflammation. This study retrospectively analyzed the prevalence and distribution of LME on CE-FLAIR images in children with MOG antibody-associated encephalitis (MOG-E). The corresponding magnetic resonance imaging (MRI) features and clinical manifestations are also presented. METHODS: The brain MRI images (native and CE-FLAIR) and clinical manifestations of 78 children with MOG-E between January 2018 and December 2021 were analyzed. Secondary analyses evaluated the relationship between LME, clinical manifestations, and other MRI measures. RESULTS: Forty-four children were included, and the median age at the first onset was 70.5 months. The prodromal symptoms were fever, headache, emesis, and blurred vision, which could be progressively accompanied by convulsions, decreased level of consciousness, and dyskinesia. MOG-E showed multiple and asymmetric lesions in the brain by MRI, with varying sizes and blurred edges. These lesions were hyperintense on the T2-weighted and FLAIR images and slightly hypointense or hypointense on the T1-weighted images. The most common sites involved were juxtacortical white matter (81.8%) and cortical gray matter (59.1%). Periventricular/juxtaventricular white matter lesions (18.2%) were relatively rare. On CE-FLAIR images, 24 (54.5%) children showed LME located on the cerebral surface. LME was an early feature of MOG-E (P = 0.002), and cases without LME were more likely to involve the brainstem (P = 0.041). CONCLUSION: LME on CE-FLAIR images may be a novel early marker among patients with MOG-E. The inclusion of CE-FLAIR images in MRI protocols for children with suspected MOG-E at an early stage may be useful for the diagnosis of this disease.
format Online
Article
Text
id pubmed-10318903
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103189032023-07-05 Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images Li, Li Liu, Wen Cai, Qifang Liu, Yuqing Hu, Wenjing Zuo, Zhichao Ma, Qiuhong He, Siping Jin, Ke Front Immunol Immunology BACKGROUND: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a newly defined autoimmune inflammatory demyelinating central nervous system (CNS) disease characterized by antibodies against MOG. Leptomeningeal enhancement (LME) on contrast-enhanced fluid-attenuated inversion recovery (CE-FLAIR) images has been reported in patients with other diseases and interpreted as a biomarker of inflammation. This study retrospectively analyzed the prevalence and distribution of LME on CE-FLAIR images in children with MOG antibody-associated encephalitis (MOG-E). The corresponding magnetic resonance imaging (MRI) features and clinical manifestations are also presented. METHODS: The brain MRI images (native and CE-FLAIR) and clinical manifestations of 78 children with MOG-E between January 2018 and December 2021 were analyzed. Secondary analyses evaluated the relationship between LME, clinical manifestations, and other MRI measures. RESULTS: Forty-four children were included, and the median age at the first onset was 70.5 months. The prodromal symptoms were fever, headache, emesis, and blurred vision, which could be progressively accompanied by convulsions, decreased level of consciousness, and dyskinesia. MOG-E showed multiple and asymmetric lesions in the brain by MRI, with varying sizes and blurred edges. These lesions were hyperintense on the T2-weighted and FLAIR images and slightly hypointense or hypointense on the T1-weighted images. The most common sites involved were juxtacortical white matter (81.8%) and cortical gray matter (59.1%). Periventricular/juxtaventricular white matter lesions (18.2%) were relatively rare. On CE-FLAIR images, 24 (54.5%) children showed LME located on the cerebral surface. LME was an early feature of MOG-E (P = 0.002), and cases without LME were more likely to involve the brainstem (P = 0.041). CONCLUSION: LME on CE-FLAIR images may be a novel early marker among patients with MOG-E. The inclusion of CE-FLAIR images in MRI protocols for children with suspected MOG-E at an early stage may be useful for the diagnosis of this disease. Frontiers Media S.A. 2023-06-20 /pmc/articles/PMC10318903/ /pubmed/37409120 http://dx.doi.org/10.3389/fimmu.2023.1152235 Text en Copyright © 2023 Li, Liu, Cai, Liu, Hu, Zuo, Ma, He and Jin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Li, Li
Liu, Wen
Cai, Qifang
Liu, Yuqing
Hu, Wenjing
Zuo, Zhichao
Ma, Qiuhong
He, Siping
Jin, Ke
Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images
title Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images
title_full Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images
title_fullStr Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images
title_full_unstemmed Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images
title_short Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images
title_sort leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318903/
https://www.ncbi.nlm.nih.gov/pubmed/37409120
http://dx.doi.org/10.3389/fimmu.2023.1152235
work_keys_str_mv AT lili leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages
AT liuwen leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages
AT caiqifang leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages
AT liuyuqing leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages
AT huwenjing leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages
AT zuozhichao leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages
AT maqiuhong leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages
AT hesiping leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages
AT jinke leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages